Log in to your Inderes Free account to see all free content on this page.
Phase Holographic Imaging PHI
0.66 SEK
-2.64 %
Less than 1K followers
PHI
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-2.64 %
-29.51 %
-43.00 %
-45.80 %
-59.51 %
-63.31 %
-72.33 %
-97.54 %
-95.32 %
PHI is active in medical technology and develops both hardware and software for quantitative analysis of living cell cultures. The HoloMonitor® products are based on non-invasive QPI technology that collects data on cell quality and are sold globally through distributors with a focus on preclinical cancer research, stem cell research and drug development. Going forward, PHI focuses on developing its products for the clinical market and in regenerative medicine. PHI has offices in Lund, Boston, and Winston-Salem.
Read moreMarket cap
41.87M SEK
Turnover
13.73K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
19.12.
2025
Interim report Q2'26
All
Press releases
ShowingAll content types
BioStock: PHI comments on expansion into veterinary IVF
Phase Holographic: PHI sets sights on IVF applications in livestock
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio